Where are we now with hormone replacement therapy?
作者信息
McPherson Klim
出版信息
BMJ. 2004 Feb 14;328(7436):357-8. doi: 10.1136/bmj.328.7436.357.
Abstract
摘要
相似文献
1
Where are we now with hormone replacement therapy?
BMJ. 2004 Feb 14;328(7436):357-8. doi: 10.1136/bmj.328.7436.357.
2
[HRT debate (hormone replacement therapy in menopause)].
Bull Cancer. 2000 Jul;87(7-8):522-4.
3
[Postmenopausal hormone replacement therapy--is there a cause of worry?].
Ugeskr Laeger. 2002 Aug 19;164(34):3974-5.
4
Does HRT increase the risk of breast cancer? Don't forget the menopausal woman!
Climacteric. 2012 Apr;15(2):103-4. doi: 10.3109/13697137.2012.665224.
5
6
[Hormone replacement therapy in menopause and risk of breast cancer].
Bull Cancer. 2003 Oct;90(10):821-31.
7
Hormone replacement therapy and mammographic screening.
J Br Menopause Soc. 2004 Jun;10(2):75, 80. doi: 10.1258/136218004774202391.
8
[Hormonal replacement therapy in postmenopause: an endless story].
Epidemiol Prev. 2002 Nov-Dec;26(6):278-9.
9
[New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use].
Lakartidningen. 2002 Jul 11;99(28-29):3031-4.
10
[Breast cancer and the use of hormones around menopause].
Ned Tijdschr Geneeskd. 2004 Jun 5;148(23):1170.
引用本文的文献
1
Screening for estrogenic and antiestrogenic activities of plants growing in Egypt and Thailand.
Pharmacognosy Res. 2011 Apr;3(2):107-13. doi: 10.4103/0974-8490.81958.
2
New evidence rekindles the hormone therapy debate.
J Fam Plann Reprod Health Care. 2010 Apr;36(2):61-4. doi: 10.1783/147118910791069277.
3
Performance of four clinical screening tools to select peri- and early postmenopausal women for dual X-ray absorptiometry.
Osteoporos Int. 2005 Jul;16(7):764-72. doi: 10.1007/s00198-004-1748-5. Epub 2004 Sep 30.
4
Hormone therapy for the ageing. Despite the negative results of recent trials, hormone replacement therapy retains enticing promises for the elderly.
EMBO Rep. 2004 Oct;5(10):938-41. doi: 10.1038/sj.embor.7400269.
5
Cardiology.
Br J Gen Pract. 2004 Sep;54(506):695-702.
本文引用的文献
1
Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial.
Climacteric. 2003 Dec;6(4):302-10; discussion 310-3.
2
Benefits and harms associated with hormone replacement therapy: clinical decision analysis.
BMJ. 2004 Feb 14;328(7436):371. doi: 10.1136/bmj.328.7436.371.
3
Clinical review 162: cardiovascular endocrinology 3: an epidemiologist looks at hormones and heart disease in women.
J Clin Endocrinol Metab. 2003 Sep;88(9):4031-42. doi: 10.1210/jc.2003-030876.
4
Breast cancer and hormone-replacement therapy in the Million Women Study.
Lancet. 2003 Aug 9;362(9382):419-27. doi: 10.1016/s0140-6736(03)14065-2.
5
Estrogen plus progestin and the risk of coronary heart disease.
N Engl J Med. 2003 Aug 7;349(6):523-34. doi: 10.1056/NEJMoa030808.
6
Hormone-replacement therapy and cardiovascular diseases.
N Engl J Med. 2003 Aug 7;349(6):521-2. doi: 10.1056/NEJMp038110.
7
From presumed benefit to potential harm--hormone therapy and heart disease.
N Engl J Med. 2003 Aug 7;349(6):519-21. doi: 10.1056/NEJMp038108.
8
Postmenopausal hormone therapy: a reversal of fortune.
Circulation. 2003 Apr 15;107(14):1830-3. doi: 10.1161/01.CIR.0000064601.65196.DF.
9
The arrogance of preventive medicine.
CMAJ. 2002 Aug 20;167(4):363-4.
10
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321.
Zotero 插件